June 2024

Collaborates with Arista Networks, Intel Corporation and joins Ultra Ethernet Consortium SEATTLE–(BUSINESS WIRE)–First paragraph, first sentence of release should read: Today, Qumulo, the simple way to manage exabyte-scale data anywhere, became the first Networked Storage supplier to join the Ultra Ethernet Consortium. The updated release reads: QUMULO’S DATA PLATFORM EMBRACES NEXT-GENERATION OF NETWORKING Collaborates with […]

WELLESLEY, Mass.–(BUSINESS WIRE)–Redpoint Global today announced that it has achieved Select tier partner status from Snowflake, the Data Cloud company. As a Select partner, Redpoint Global can accelerate the digital transformation of its joint customers who can fully leverage the performance, flexibility and near-infinite scalability of the Snowflake AI Data Cloud. “Reaching Select tier partner

DUBLIN–(BUSINESS WIRE)–The “Europe Next-Generation Optical Fiber Market (Multicore and Hollow Core Fiber): Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The Europe next-generation optical fiber market (multicore and hollow core fiber) (excluding U.K.) is projected to reach $279.1 million by 2031 from $34.6 million in 2022, growing at a CAGR of 26.1%

NAPERVILLE, Ill.–(BUSINESS WIRE)–Azuba (formerly Napersoft), a leading cloud-based health ecosystem that facilitates the exchange of lifetime patient clinical records for over 90% of all clinical data in the USA, is excited to announce the appointment of David Corso as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO). Leveraging its Customer Communication Management

PanCAN’s Know Your Tumor precision medicine service will be used to further validate Genialis krasID biomarker performance in pancreatic cancer CHICAGO–(BUSINESS WIRE)–#ISO27001—Genialis, the RNA-biomarker company, today announced a new partnership with the Pancreatic Cancer Action Network (PanCAN) to expand the validation of the Genialis krasID biomarker in the pancreatic cancer histology. Genialis krasID is a

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Industry Outlook, 2024” report has been added to ResearchAndMarkets.com’s offering. The leading trends shaping the global pharmaceutical landscape are covered in this analysis. The study period is 2021-2028, with 2023 as the base year and 2024-2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM)